Latest News & Features
Africa
The “Global Generic Drugs Market 2016-2020” report predicts that the expiry of patents for branded drugs, worth $150 billion, will allow generic companies to prosper by 2020. 15 June 2016
Big Pharma
The German Federal Supreme Court has granted Eli Lilly an appeal in the patent infringement case against its rival Actavis regarding the Alimta drug. 15 June 2016
Big Pharma
The English High Court made its decision on the UK Hospira and Cubist Pharmaceuticals patent dispute last Friday, June 10, concluding that three Cubist-owned patents are invalid. 15 June 2016
Americas
Leo Pharma has filed suit against Perrigo in the US District Court for the District of Delaware alleging patent infringement. 14 June 2016
Americas
AstraZeneca has filed a citizen petition to the US Food and Drug Administration requesting it to wait until 2023 before approving generic versions of Crestor, a cholesterol treatment. 14 June 2016
article
The European Patent Office held the European Inventor Award in Lisbon on June 9, when it showcased some of the leading innovators in Europe and the rest of the world. 14 June 2016
Americas
US authorities arrested three individuals on Friday, June 10 on suspicion of running a counterfeit drug operation. 13 June 2016
Americas
Colombia’s government will set a new price for Novartis’s cancer drug Gleevec following a recent dispute. 13 June 2016
Americas
Teva Pharmaceutical announced last Friday, June 10, that the US District Court for the District of Delaware ruled that four patents for the Treanda injection are valid. 13 June 2016
Big Pharma
Law firm Allen & Overy has hired Marjan Noor as a partner in the firm’s intellectual property practice in London. 10 June 2016